Veeva Systems (VEEV)
(Delayed Data from NYSE)
$281.35 USD
-2.85 (-1.00%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $281.29 -0.06 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VEEV 281.35 -2.85(-1.00%)
Will VEEV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VEEV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VEEV
Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
VEEV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
Wall Street Analysts See Veeva (VEEV) as a Buy: Should You Invest?
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
Other News for VEEV
Franklin Small-Mid Cap Growth Fund Q2 2025 Commentary
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality | VEEV Stock News
Veeva Systems Larger Than S&P 500 Component Target
Veeva Systems Reaches Analyst Target Price
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics